ArticleEMBO molecular medicine2018
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.
Maicol Mancini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papertrialcites it